|
Caragana
|
B01.650.940.800.575.912.250.401.098 |
|
|
RNA Polymerase III
|
D012320 |
[A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II.
] |
|
DNA-Directed RNA Polymerases
|
D012321 |
[Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992).
] |
|
Lutembacher Syndrome
|
C16.131.240.400.560.375.518 |
|
|
Heart Septal Defects, Atrial
|
C16.131.240.400.560.375 |
|
|
Uromodulin
|
D12.776.543.550.418.850 |
|
|
RNA Precursors
|
D012322 |
[The product of RNA polymerase prior to any post-transcriptional modifications (RNA PROCESSING, POST-TRANSCRIPTIONAL), i.e. RNA copies from DNA that exactly represent the genome sequence.
, RNA transcripts of the DNA that are in some unfinished stage of post-transcriptional processing (RNA PROCESSING, POST-TRANSCRIPTIONAL) required for function. RNA precursors may undergo several steps of RNA SPLICING during which the phosphodiester bonds at exon-intron boundaries are cleaved and the introns are excised. Consequently a new bond is formed between the ends of the exons. Resulting mature RNAs can then be used; for example, mature mRNA (RNA, MESSENGER) is used as a template for protein production.
] |
|
Caesalpinia
|
B01.650.940.800.575.912.250.401.093 |
|
|
RNA Processing, Post-Transcriptional
|
D012323 |
[Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein.
] |
|
Cajanus
|
B01.650.940.800.575.912.250.401.094 |
|
|
Quadriplegia
|
C10.597.622.760 |
|
|
Smad3 Protein
|
D051900 |
[A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. Activated Smad3 can bind directly to DNA, and it regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.
] |
|
Warts
|
C01.925.256.650.810 |
|
|
Papillomavirus Infections
|
C01.925.256.650 |
|
|
Smad4 Protein
|
D051901 |
[A signal transducing adaptor protein and tumor suppressor protein. It forms a complex with activated RECEPTOR-REGULATED SMAD PROTEINS. The complex then translocates to the CELL NUCLEUS and regulates GENETIC TRANSCRIPTION of target GENES.
] |
|
Smad5 Protein
|
D051902 |
[A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and is essential for PHYSIOLOGICAL ANGIOGENESIS.
] |
|
Nuclear Factor 45 Protein
|
D051903 |
[A protein subunit that takes part in forming nuclear factor 90 protein complexes.
] |
|
Smad8 Protein
|
D051904 |
[A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS and regulates BONE MORPHOGENETIC PROTEIN signaling.
] |
|
Smad6 Protein
|
D051905 |
[An inhibitory Smad protein that negatively regulates the SIGNAL TRANSDUCTION PATHWAYS from BONE MORPHOGENETIC PROTEIN RECEPTORS. Smad6 inhibits PHOSPHORYLATION of SMAD2 PROTEIN and SMAD3 PROTEIN.
] |
|
Smad7 Protein
|
D051906 |
[An inhibitory smad protein that associates with TRANSFORMING GROWTH FACTOR BETA RECEPTORS and BONE MORPHOGENETIC PROTEIN RECEPTORS. It negatively regulates SIGNAL TRANSDUCTION PATHWAYS by inhibiting PHOSPHORYLATION of RECEPTOR-REGULATED SMAD PROTEINS.
] |
